Evidence map›Paper›PMID 33215291›Full record

ArticleWorld journal of microbiology & biotechnology2020

The prebiotics (Fructo-oligosaccharides and Xylo-oligosaccharides) modulate the probiotic properties of Lactiplantibacillus and Levilactobacillus strains isolated from traditional fermented olive.

Houssam Abouloifa, Nastaran Khodaei, Yahya Rokni, Salwa Karboune, Milena Brasca, Guy D'Hallewin, Riadh Ben Salah, Ennouamane Saalaoui, Abdeslam Asehraou

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Dairy associations for the targeted control of opportunistic Candida.World journal of microbiology & biotechnology · 2021
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 5 countries.

Houssam AbouloifaLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed Premier University, 60 000, Oujda, Morocco.
Nastaran KhodaeiDepartment of Food Science and Agricultural Chemistry, McGill University 21, Macdonald Campus, 111 Lakeshore, Ste Anne de Bellevue, QC, H9X 3V9, Canada.
Yahya RokniLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed Premier University, 60 000, Oujda, Morocco.
Salwa KarbouneDepartment of Food Science and Agricultural Chemistry, McGill University 21, Macdonald Campus, 111 Lakeshore, Ste Anne de Bellevue, QC, H9X 3V9, Canada.
Milena BrascaInstitute of Sciences of Food Production, National Research Council of Italy, Via Celoria 2, 20133, Milano, Italy.
Guy D'HallewinInstitute of Sciences of Food Production, National Research Council of Italy, Traversa la Crucca, 3 Loc. Baldinca, 07100, Sassari, Italy.
Riadh Ben SalahLaboratory of Microorganisms and Biomolecules, Centre of Biotechnology of Sfax, BP: 1177, 3018, Sfax, Tunisia.
Ennouamane SaalaouiLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed Premier University, 60 000, Oujda, Morocco.
Abdeslam AsehraouLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed Premier University, 60 000, Oujda, Morocco. a.asehraou@ump.ac.ma.ORCID http://orcid.org/0000-0001-5195-8217
Mohamed I University · MAInstitute of Sciences of Food Production · ITMcGill University · CACentre of Biotechnology of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to examine the influence of two prebiotics, fructo-oligosaccharides (FOS) and xylo-oligosaccharides (XOS), on probiotic properties (resistance to low pH and bile salt, hydrophobicity and auto-aggregation), metabolites production, and antimicrobial activity of probiotic Lactiplantibacillus (L. pentosus S42 and L. plantarum S61) and Levilactobacillus (L. brevis S27) strains isolated from fermented olive. The results demonstrated the ability of strains to ferment XOS more than FOS as a sole carbon source, resulting in pH reduction. The prebiotics (FOS and XOS) significantly increased (p < 0.05) their survival in gastro-intestinal conditions (low pH and 0.3% of bile salts), as well as their hydrophobicity, auto-aggregation and production of proteins, compared to glucose (control). The major organic acids produced by Lactiplantibacillus and Levilactobacillus strains, were oxalic, malic and lactic acids from FOS, XOS and glucose, respectively. No antimicrobial activity was observed from cell-free supernatant (CFS) of Lactiplantibacillus and Levilactobacillus strains obtained from FOS. In the presence of XOS the organic acids, produced by Lactiplantibacillus and Levilactobacillus strains, were more diverse with high contents, and exhibited higher antifungal and antibacterial activities, more than that of FOS and glucose. The combination of L. plantarum S61 and XOS demonstrated the highest inhibition zones ranges of 20.7-22.2 mm against pathogenic bacteria and 29.2-30 mm against yeasts. This combination can be used in production of antifungal preservatives and pharmaceuticals, against pathogenic and spoilage yeasts.

Indexed as

Anti-Infective AgentsBile Acids and SaltsFermentationGlucuronatesHydrophobic and Hydrophilic InteractionsLactic AcidLactobacillaceaeMalatesMicrobial Sensitivity TestsOleaOligosaccharidesOxalatesPrebioticsProbioticsSecondary MetabolismAnti-Infective AgentsBile Acids and SaltsfructooligosaccharideGlucuronatesLactic AcidMalatesmalic acidOligosaccharidesOxalatesPrebioticsxylooligosaccharideAntimicrobialFOSLactiplantibacillusLevilactobacillusPrebioticProbioticXOS

Identifiers

PMID33215291
OpenAlexW3103157612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.